Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Azurity – Recall of Zenzedi® (dextroamphetamine)
January 24, 2024 - Azurity announced a consumer level recall of one lot of Zenzedi (dextroamphetamine) 30 mg tablets because a bottle labeled as Zenzedi contained carbinoxamine tablets.
